> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest FDA Warning Letters
- URL: https://www.fdaweb.com/latest-fda-warning-letters-212/
- Published: 2019-10-08T12:00:00.000Z
- Updated: 2026-09-15T01:54:53.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145194

FDA has posted its latest batch of Warning Letters. They can be accessed by clicking on the link following each letter.

**Herbal Healer Academy**, Mountain View, AR (9/12): FDA inspected the firm 11/2018 and found multiple violations of the Federal Food, Drug, and Cosmetic Act. For example, the company takes orders for products that are considered to be unapproved new drugs and misbranded drugs because of health claims made on its Web site. The letter also cites the company for misbranded homeopathic drugs and adulterated dietary supplements. It notes that during the inspection, investigators observed GMP deviations for dietary supplements. To view the letter, click [here](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/herbal-healer-academy-inc-570957-09122019?ref=fdaweb.com).

**NuCare Pharmaceuticals**, Orange, CA (9/26): FDA recently reviewed the firm’s listing files from 8/2017 to the present and identified many instances where the listing information failed to comply with the applicable requirements. The company also failed to address many of the listing deficiencies detailed in multiple deficiency letters. To view the letter, click [here](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nucare-pharmaceuticals-inc-588096-09262019?ref=fdaweb.com).